Literature DB >> 5768392

Marked elevations of serum glutamic oxalacetic transaminase and lactic dehydrogenase activity in chronic extraheptic biliary disease.

A Abbruzzese, R L Jeffery.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5768392     DOI: 10.1007/BF02235945

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


× No keyword cloud information.
  19 in total

1.  A VIRAL HEPATITIS STUDY ON TAIWAN. REVIEW OF 303 CASES COLLECTED FROM JULY, 1958, TO JUNE, 1962.

Authors:  S C SUN; S M CHUONG; J W FRESH
Journal:  Arch Intern Med       Date:  1965-03

2.  Serum enzymes in hepatic disease.

Authors:  M WEST; H J ZIMMERMAN
Journal:  Med Clin North Am       Date:  1959-03       Impact factor: 5.456

3.  Reactive changes of enzyme activities in serum and liver as symptoms of acute syndrome.

Authors:  W H HAUSS; H J LEPPELMANN
Journal:  Ann N Y Acad Sci       Date:  1958-10-13       Impact factor: 5.691

4.  Transaminase activity in suspensions of parenchymatous liver cells.

Authors:  K S HENLEY; H S WIGGINS; H M POLLARD; E DULLAERT
Journal:  Ann N Y Acad Sci       Date:  1958-10-13       Impact factor: 5.691

5.  [The relation between serum glutamic oxalacetic transaminase and alkaline phosphatase in jaundice. Its value for the differential diagnosis of parenchymatous and obstructive jaundice].

Authors:  F JORGENSEN; S MADSEN
Journal:  Nord Med       Date:  1960-12-15

6.  Urinary lactic dehydrogenase in renal disease.

Authors:  S B ROSALKI; J H WILKINSON
Journal:  Lancet       Date:  1959-09-12       Impact factor: 79.321

7.  The diagnostic, prognostic and epidemiologic significance of serum glutamic oxaloacetic transaminase (SGO-T) alterations in acute hepatitis.

Authors:  G JERVIS; J S LADUE; F WROBLEWSKI
Journal:  Ann Intern Med       Date:  1956-11       Impact factor: 25.391

8.  The Structure of the Liver after Recovery from Epidemic Hepatitis.

Authors:  B Lucké
Journal:  Am J Pathol       Date:  1944-05       Impact factor: 4.307

Review 9.  The transaminase tests in liver disease.

Authors:  R J Clermont; T C Chalmers
Journal:  Medicine (Baltimore)       Date:  1967-03       Impact factor: 1.889

10.  Serum transaminase activity in liver and biliary tract diseases.

Authors:  V Percic; S Stojsic; T Hegedis; M Ostrogonac
Journal:  Am J Gastroenterol       Date:  1966-05       Impact factor: 10.864

View more
  5 in total

1.  Misleading SGOT (aspartate aminotransferase) values in obstructive jaundice due to pancreatic carcinoma.

Authors:  P B Gregory; D P Cooney
Journal:  Am J Dig Dis       Date:  1976-06

2.  The clinical significance of the SGOT test.

Authors:  R R Babb
Journal:  Calif Med       Date:  1973-05

3.  Very high levels of SGOT and LDH in patients with extrahepatic biliary tract obstruction.

Authors:  A L Ginsberg
Journal:  Am J Dig Dis       Date:  1970-09

Review 4.  Clinical use of serum enzymes in liver disease.

Authors:  J J Reichling; M M Kaplan
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

5.  Clinicopathological features of choledocholithiasis patients with high aminotransferase levels without cholangitis: Prospective comparative study.

Authors:  Cheal Wung Huh; Sung Ill Jang; Beom Jin Lim; Hee Wook Kim; Jae Keun Kim; Jun Sung Park; Ja Kyung Kim; Se Joon Lee; Dong Ki Lee
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.